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Abstract
Background: Smoking is one of the leading preventable causes of illness and premature death worldwide. Despite
a variety of effective treatments, relapse rates remain high, and novel, innovative interventions are needed in order
to reduce the global prevalence of smoking. Research has indicated that deficits in the ability to inhibit a response
(referred to as response inhibition) is a predictor of relapse and subsequently, targeting this potentially modifiable
risk factor may lead to improvements in smoking outcomes. Indeed, in recent years, stimulus-specific response
inhibition training has emerged as a potentially efficacious intervention to reduce unwanted/unhealthy behaviours
such as alcohol and unhealthy food consumption. As such, the present trial is the first to evaluate the real-world
efficacy of response inhibition smoking training (INST) in a sample of adult heavy smokers.
Methods/design: This randomised controlled trial will recruit nicotine dependent smokers aged between 18 and
60 using social media and advertisements in Victoria, Australia. The sample target was 150 to account for drop out
and non-adherence. Once informed consent has been obtained, participants complete a range of baseline measures
during a face to face interview. Participants are randomly allocated to one of two online training conditions: an
intervention training group (INST), which requires participants to exercise response inhibition towards smoking-related
stimuli; or an active control group, which requires participants to exercise response inhibition towards household items
and does not include any smoking-related stimuli. They complete the first training session during the interview to
ensure the training protocol is clear. Both groups are instructed to complete a further 13 training sessions (1 per day)
at home on their computer and follow-up phone calls will be conducted at three time points: post-intervention,
one-month and three months. The primary outcomes are: a) rates of smoking cessation and; b) reduction in the
quantity of average daily smoking at post-intervention, one and three months follow-up.
Discussion: There is a pressing need to develop novel and innovative smoking interventions. If proven to be effective,
INST could make a highly cost-effective contribution to improvements in smoking intervention outcomes.
Trial registration: The trial was prospectively registered with the Australian New Zealand Clinical Trials Registry 17th
February 2017. Trial ID: ACTRN12617000252314.
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Background
Tobacco smoking is one of the leading preventable
causes of illness and premature death worldwide. It is
the second largest contributor to the burden of disease
globally, with 134.2 million years lost to disability, illness
and premature death [1]. In 2013, 6.1 million people
died globally as a result of tobacco use [1], and, if trends
persist, this number will exceed 8 million by the year
2030 [2]. Furthermore, tobacco use has been found to
cost the global economy more than US$1 trillion each
year in healthcare expenditures and lost productivity [3].
As smoking remains at unacceptable levels across the
world [4, 5], examinations of effective and accessible
smoking cessation treatments are crucial in reducing the
global burden of smoking on public health.
Currently, pharmacological and psychosocial interven-
tions have the most support as efficacious treatments for
the cessation of smoking [6–10]. However, despite the
positive outcomes associated with these interventions,
most smokers do not seek formal treatment to reduce
smoking [11] and existing treatments can entail several
limitations. First, smokers have reported concerns re-
garding adverse side-effects of pharmacological treat-
ments which have impacted treatment uptake and
long-term adherence [12–14]. Second, the long-term
cost of pharmacological and psychosocial interventions,
which can be more expensive than cigarettes themselves,
often prohibit individuals from accessing smoking cessa-
tion treatments. This is particularly relevant given that:
1) the financial costs of tobacco are one of the primary
reasons underpinning quit intentions and attempts [4,
15, 16] and; 2) the incidence of smoking is increasing
most rapidly in developing nations who have the lowest
levels of disposable income [5]. Therefore, there is a crit-
ical need for accessible and cost-efficient interventions
for smoking cessation. Third, relapse rates remain con-
sistently high following treatment [17] and, the vast ma-
jority will relapse within five to 10 days of treatment
cessation [18, 19]. Thus, a substantial proportion of indi-
viduals attempting to quit smoking fail to achieve
long-term abstinence, inviting the question: what modifi-
able risk factors for smoking relapse may be targeted to
increase abstinence rates or at the very least result in re-
duction of level of smoking?
Previous research indicates that deficits in response in-
hibition are a strong predictor of relapse for smokers fol-
lowing a quit attempt [20, 21]. Research suggests that
recently abstinent smokers experience heightened diffi-
culties with response inhibition [22, 23], indicating that
targeting this may assist in preventing relapse. Import-
antly, a meta-analysis [23] supports evidence showing
that individuals dependent on substances such as co-
caine and alcohol may experience deficits in response in-
hibition. Furthermore, Yin and colleagues [24] found
that a group of smokers reported response inhibition
deficits on the GNG task. Taken together this provides
some evidence that smokers may experience difficulties
with response inhibition. Of significance is that individ-
uals who reported higher nicotine dependence experi-
enced greater deficits in response inhibition than those
of lower use or dependence [25, 26]. Given that heavier
smokers find it more difficult to quit [27, 28], response
inhibition deficits may be an effective target for treat-
ment in these individuals.
Indeed, response inhibition training interventions uti-
lising tasks such as the go/no-go (GNG) task and stop
signal task (SST) focus on training successful inhibition
of a habitual or pre-potent response by pairing pictorial
cues of the targeted behaviour with stop signals or no/go
cues [29]. The GNG task targets automatic bottom-up
response inhibition (or action restraint) by consistently
pairing no-go cues with the target stimuli [30, 31], while
the SST targets top-down inhibitory control (or action
cancellation) as stop signals occur after an initiated re-
sponse and are mapped only to a proportion of target
stimuli [32]. These tasks have recently been examined to
reduce alcohol and food intake, yielding efficacious re-
sults [33]. For example, Houben, Havermans, Neder-
koorn, and Jansen [34] randomly assigned 57 heavy
alcohol drinkers to receive one of two training condi-
tions: a beer/no-go condition, where alcohol-related
stimuli were consistently paired with a stopping re-
sponse, or a beer/go condition, where participants al-
ways responded to alcohol-related stimuli. Compared to
participants in the beer/go condition, those who were
trained to inhibit their response towards alcohol-related
stimuli (beer/no-go) reported significantly less alcohol
intake. Similar findings were reported by Jones and Field
[35]. In their study, following motor inhibition training
utilising a modified SST, heavy social drinkers were
found to consume significantly less alcohol in a subse-
quent ad libitum taste test.
More recently Lawrence et al. [36] implemented an
internet-delivered response inhibition training interven-
tion for food among 83 overweight and obese adult par-
ticipants. Participants were randomly allocated to
receive four 10-min training sessions completed online.
In the intervention group, high-calorie foods were con-
sistently paired with no-go signals and in the control
group, non-food stimuli were consistently paired with
no-go signals. At one-week follow-up, participants in the
food no-go condition consumed significantly less food,
showed significant weight loss, and had decreased posi-
tive evaluations towards high calorie foods compared to
controls. At 6 month follow-up, participants in the inter-
vention group displayed significantly higher average
weight loss (2.21 kg) compared to controls (0.36 kg).
These findings are consistent with a previous trial [37]
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that compared two interventions for losing weight: an
implementation intention intervention that instructed
participants to plan reminders for dieting and a response
inhibition intervention that paired no-go responses with
food-related stimuli. Findings indicated that participants
who completed only the response inhibition training re-
ported significant weight loss after four training sessions.
Together, these results indicate that response inhibition
training can be effectively delivered online, promoting
greater accessibility and cost-efficiency of these types of
interventions.
Two meta-analyses have found that inhibitory control
training resulted in an overall significant effect (albeit a
small effect size), with GNG training yielding larger
(medium) effect sizes than SST training [29, 33]. Ac-
cording to the Behaviour Stimulus Interaction (BSI) the-
ory [38] behavioural changes induced by the GNG
training are mediated by changes in evaluations of the
stimuli used in the task. That is, positively regarded
stimuli will become associated with negative affect as a
result of consistently being paired with no-go cues. This
is thought to devalue the stimuli and minimise the likeli-
hood of approach behaviours occurring towards the
stimuli in real life. This theory has been supported by
evidence in studies targeting alcohol consumption that
suggest a mediating effect of changes in implicit atti-
tudes on alcohol intake [34, 39]. In the food domain,
there is evidence of devaluation of trained no-go food
stimuli as assessed by visual analogue scales [36, 40, 41].
Another proposed mechanism of response inhibition
training is the automatic inhibition hypothesis (AIH)
[32], which posits that automatic response inhibition can
develop over practice if stimuli are consistently associ-
ated with stopping [42, 43]. These two potential mediat-
ing hypotheses will be investigated in this trial.
In summary, given that significant effects of the GNG
task were found despite the use of non-clinical samples,
it was expected that these interventions would be par-
ticularly effective with smokers as smoking receives the
most frequent reinforcement compared with other
dependent populations, with multiple smoking sessions
each day. Furthermore, we hypothesise that it will be
particularly beneficial for heavy smokers who report the
greatest difficulty with impulse control [4]. This is sug-
gested by findings that stronger nicotine dependence is
associated with poorer inhibitory control [44]. Thus, this
is the first study to use the GNG task in a sample of in-
dividuals who have a Tobacco Use Disorder according to
DSM-5 criteria and who wish to quit/reduce smoking.
As previous studies have found response inhibition
training to be effective even when administered over the
internet [36, 37], this study delivered the training para-
digm online. This enabled the intervention to be access-
ible, convenient and cost-efficient for individuals and
further contribute to reducing the burden on other
treatment services and resources. The study is a rando-
mised controlled trial (RCT) examining the efficacy of
response inhibition training in reducing smoking in
heavy dependent smokers. It is implemented in accord-
ance with CONSORT guidelines, and involves collecting
follow-up data from participants at 1 month and 3
months post-intervention.
Primary hypotheses
1. Smokers who received smoking-related response in-
hibition training (INST program) would report sig-
nificantly higher cessation rates compared to those
in the active control condition at the end of the
intervention, 1 month and 3 months post-intervention.
2. Smokers who received smoking-related response
inhibition training (INST program) would report
significantly less cigarette consumption compared
to smokers in the active control condition at the
end of the intervention, 1 month and 3 months
post-intervention.
Secondary hypotheses
1 Smokers who received smoking-related response
inhibition training (INST program) would report
significantly less craving for cigarettes compared to
smokers in the active control condition at the end
of the intervention and 1 month and 3 months
post-intervention.
2 Smokers who received smoking-related response
inhibition training (INST program) would report
significantly lower levels of nicotine dependence
compared to smokers in the active control condition
at the end of the intervention and 1 month and 3
months post-intervention.
Predictor/moderator hypotheses
1. Individuals reporting high levels of impulsivity
would report significantly improved outcomes from
the intervention training compared to those with
lower levels of impulsivity.
2. Individuals who completed a greater number of
sessions (i.e., dose) would report significantly
improved outcomes from the intervention training
compared to those who completed less sessions.
Mediator hypotheses
1. The effects of INST training on level of smoking
would be mediated by devaluation of smoking
Staiger et al. BMC Public Health         (2018) 18:1226 Page 3 of 11
stimuli as measured by a devaluation of smoking
images task.
2. The effects of INST training on level of smoking
would be mediated by an independent measure of
response inhibition (SST).
The following exploratory question was proposed:
1. Do smokers who receive smoking-related response
inhibition training (INST program) report
significantly higher levels of self-confidence and
motivation to quit smoking compared to smokers
in the active control condition at the end of the
intervention, 1 month and 3 months post-intervention.
Methods/design
Design
This is a 2-group parallel-block double-blind randomised
controlled trial testing the efficacy of an intervention com-
pared to an active control training. The intervention train-
ing is a smoking version of the food GNG training task in
Lawrence et al. [36]. The active control training is similar
to the control training in Lawrence et al. [36], with no-go
training to household items. The Deakin University
Human Research Ethics Committee (DUHREC) reviewed
and approved all relevant study materials (Project ID:
2015–298). The trial was registered with the Australian
New Zealand Clinical Trials Registry (Trial ID:
ACTRN12617000252314; see Additional file 1: Table S1
for items from the World Health Organisation Data Set as
per Spirit Guidelines). No study protocol amendments
were made once the trial commenced and this protocol
was originally submitted to this journal 1 November 2017.
Procedure
The following sections describe the study procedure. See
Table 1 for an overview.
Initial screening
Participants were adult smokers aged between 18 and
60 years, recruited through social media and advertisements
in Victoria, Australia who had a desire to quit smoking.
Inclusion criteria
 Aged between 18 and 60 years.
 Smoke, on average, a minimum of 10 cigarettes per
day for the last 12 months.
 Meet criteria for moderate or above Tobacco Use
Disorder defined by the DSM-5 [45].
 Be motivated to make a quit attempt during the
training stage of the intervention.
 Completed at least Year 9 (or equivalent) schooling.
 Have computer and internet access during the
intervention phase of the study.
Exclusion criteria
 Primarily uses electronic cigarettes on a daily basis.
 Non-smoking period of 2 weeks or more in the past
3 months.
 Currently using anti-craving medication.
 Using nicotine-replacement therapy during the
intervention period.
 Self-reported problematic alcohol or drug(s) use
other than tobacco.
 Reported a traumatic or acquired brain injury or a
loss of consciousness for more than 30 min.
 Reported current use of psychotropic medication
such as anti-depressant, anti-psychotic and/or anxio-
lytic medication.
Interested participants were invited to contact the re-
search team via email. They were screened over the
phone/online to determine their eligibility. Participants
who met the inclusion criteria were invited to participate
in the study and attended a face to face interview in
order to sign the consent form, collect baseline measures
and participate in the first online training session.
Baseline assessment (T1)
At the beginning of the baseline interview session, partici-
pants read the plain language statement and if in agree-
ment signed the consent form. They were requested to
report any adverse events or consequences which will be
reported in the flow chart of the primary outcomes paper.
They were informed that they were able to withdraw from
the study at any time. They were asked to indicate
whether they would like to receive a summary of the trial
findings following completion of data analyses. Partici-
pants were informed that they would receive one of two
brain training tasks as the aim of the study was to investi-
gate which one was more effective. While they were in-
formed that the task incorporated a “variety of visual
images”, the types of images were not specified to prevent
participants from identifying if they were in the control
group and hence we propose that participants were likely
blind to the nature of the intervention and whether they
were randomised to an active condition.
Participants completed a battery of questionnaires
(outlined in Table 1), and completed ratings of their
craving, motivation and self-efficacy. Following the com-
pletion of the questionnaires, participants completed rat-
ings of stimulus evaluation test and a smoking stop
signal task (SST), an independent measure of response
inhibition separate to the response inhibition training.
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Randomisation
Immediately following the completion of the baseline
assessment, participants began the online training
task. Participants were automatically randomised to
either the intervention or the control training task via
a pre-computed randomisation procedure. A per-
muted block randomisation procedure was utilised
[46] whereby participants were allocated to the inter-
vention or control group through the use of a ran-
domly generated number. The permuted blocks were
organised in groups of ten, the details of which were
not known by investigators involved with the adminis-
tration of the trial. The use of the permuted block ran-
domisation process ensures that intervention group
numbers will be balanced at the end of each block and
is thus the recommended process in studies with
smaller samples.
Upon finishing this task participants were instructed
to complete the online training task once per day for the
next 13 days, totalling 14 sessions. They were asked to
rate their smoking craving level before and after each
training session. Twice per week, participants were sent
text reminders to complete the training. All data from
the online training task and outcome measures were se-
curely stored on the Deakin University server and linked
to an anonymous participant ID number such that only
de-identified data were available to researchers. The data
was checked for training task performance accuracy and
Table 1 SPIRIT Flow Diagram of the schedule for participants and data collection for the INST study
STUDY PERIOD
Follow-Up Period
Enrolment Baseline (T1)
and Allocation
Training
Period
Post-Intervention (T2) 1-Month Post-
Intervention (T3)
3-Months Post-
Intervention (T4)
Close-out
TIMEPOINT -t1 t0-t1 t2 – t14 t15 t45 t105 tx
ENROLMENT:
Eligibility screen X
Informed consent X X
Obtain Contact Information X X
Allocation X
INTERVENTIONS:
INST intervention X X
Control training X X
ASSESSMENTS:
Demographic Questions X
TLFB X X X X
FTND X X X X
DASS X X X X
AUDIT X X
BIS-11 X X X X
Stimulus Evaluation Test X X X X
SST X X X
Craving Rating X X X X X
Motivation Rating X X X X
Confidence Rating X X X X
Time of last cigarette X X
CLOSE-OUT: X
Data-analysis X
Debriefing of participants X
Documentation and Dissemination
of Findings
X
t refers to days (from t1 onwards). TLFB Timeline Follow-Back interview, FTND Fagerström Test of Nicotine Dependence, DASS Depression Anxiety and Stress Scale,
AUDIT Alcohol Use Disorders Identification Test, BIS-11 Barrett Impulsiveness Scale, SST Stop Signal Task
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participant adherence to the training protocol by a re-
search assistant who was independent from investigators
and not involved in data collection or analyses.
Inhibition training task
The intervention is an online GNG training task as devel-
oped by Lawrence et al. [36], modified to incorporate im-
ages of smoking. The task included nine smoking images
(or household items in the control group), nine relaxation
images (or household items in the control group) and 18
neutral filler images presented on the left or right of the
computer screen (see Fig. 1). Each image was presented for
1250 ms followed by a 1250 ms inter-stimulus interval. Par-
ticipants were instructed to indicate whether the image is
located to the left or the right of the screen using the keys
“C” and “M” respectively on their keyboard. On half of the
trials, the frame around the picture was bolded and the par-
ticipants were required to not respond (no-go trials). On
the other half of the trials the frame was not bolded (go tri-
als) and the participant were required to respond as quickly
as possible. During each training session participants com-
pleted 6 training blocks, with each of the 36 images pre-
sented once per block. At the end of each block,
participants were provided with feedback on their accuracy
and mean correct go reaction time and will be encouraged
to continue trying to beat their own score. Each training
session will last for approximately 10 min. Participants were
asked to complete the training at home in a quiet place and
preferably, when they experienced cravings for a cigarette.
Intervention group
The intervention consisted of nine smoking-related im-
ages, nine relaxing images.
(i.e. depicting relaxing/enjoyable activities), and 18
neutral filler pictures (e.g. clothing). For the intervention
group, the smoking-related pictures were always “no-go”
trials and the non-smoking pictures were always “go” tri-
als. The neutral pictures were equally “go” and “no-go”
trials (see Fig. 1). The neutral filler pictures were incor-
porated to prevent participants from easily identifying
the associative rules of the task and to ensure the task
remains challenging and engaging.
Control group
In the control group, participants complete a similar
task to the smoking intervention group except that ran-
domly presented 18 images of household objects replace
the 18 smoking and relaxation images. The household
images were presented equally as “go” and “nogo” trials.
Post-intervention (T2)
At the completion of the two-week intervention period,
participants are contacted via phone by a researcher naïve
to the group randomisation (i.e. a different researcher to
the one who conducted the baseline interview). They re-
ceive a text message reminder 24-h prior to confirm the
time of the phone call. During these phone interviews,
participants are asked to provide details about their use of
cigarettes and nicotine replacement therapies or
anti-craving medications over the previous 2 weeks. At
the conclusion of this interview, participants are emailed a
link to complete the same battery of questionnaires, rat-
ings of their craving, motivation and self-efficacy and SST
(completed last) as completed at baseline (T1).
One-month and three-months follow-up (T3 and T4)
Follow-up at 1 month (T3) and 3 months (T4) are con-
ducted in the same manner as T2. The two follow-up time
points are identical with the exception that the SST was
not completed at T3 only in T4 to reduce participant bur-
den. At the completion of each time point, participants
were mailed a $20 gift card. At the conclusion of the data
collection period, participants in the control group are of-
fered the opportunity to complete the smoking-related re-
sponse inhibition training.
Measures
This study used information from a face-to-face interview
session (T1) and phone interviews (T2, T3 and T4), in
addition to self-report questionnaires, a cognitive task and
a stimulus evaluation test. A list of measures used at each
assessment point is provided in Table 1. Demographic in-
formation, such as age, gender, socioeconomic status and
number of years of smoking, were collected at baseline.
Researcher-administered measures
Timeline Follow-Back (TLFB) [47, 48]
The TLFB is a calendar-based assessment of daily
cigarette use for periods of time ranging from 1 to
Fig. 1 Overview of the “go” and “no-go” trials in the treatment
condition of the GNG task. Image source (clockwise from top left) -
permission granted: Pixabay [71]; Studio Art/Shutterstock [72];
Natalia S. Lawrence (Author)
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12 months prior to assessment. Initially developed to as-
sess alcohol consumption, the TLFB has since been uti-
lised to assess a variety of substance use inclusive of
cigarette use [47]. Memory aids are used to enhance re-
call of certain time-periods in order to retrospectively
estimate number of cigarettes used for each date. The
cigarette TLFB has shown high test-retest reliability and
temporal stability across both clinical and non-clinical
participants [47].
Self-report measures
Fagerström Test for Nicotine Dependence (FTND) [49]
The FTND is a six-item self-report questionnaire of nico-
tine dependence. Dichotomous items (yes or no) are
scored as 0–1, and options for categorical items are scored
0–3. The FTND has a maximum score of 10, with higher
scores indicating greater nicotine dependence. The FTND
demonstrates moderate internal consistency (α = .61) and
has been validated in smokers from the general population
[48] and in a clinical sample [50].
Craving for cigarettes
A one-item question utilising a 100 mm slider scale mea-
sures craving from “not at all” to “extremely”. Participants
respond to the question “How much are you currently
craving a cigarette”. A slider bar is presented at the left
end of the scale and participants will click and drag the
bar along the scale to indicate their response. It has been
found that a single measure of craving is just as reliable
and sensitive as self-report questionnaires for measuring
craving for smoking [51, 52]. Slider scales are considered
to be an engaging type of interface [53] and are regarded
as a psychometrically acceptable measurement [54].
Depression, Anxiety and Stress Scale (DASS-21) [55]
The DASS-21 is a 21-item measure consisting of three
subscales: depression, anxiety, and stress. Participants
are asked to use a four-point Likert scale to rate the ex-
tent to which they have experienced the state described
over the past week. The DASS has excellent internal
consistency for the total scale (α = .97), and each sub-
scale (Depression = .96; Anxiety = .92; Stress = .95) has
high test-retest reliability and acceptable construct and
convergent validity [56].
Alcohol Use Disorders Identification Test (AUDIT) [57]
The AUDIT is a 10-item measure of alcohol problems.
Questions relate to frequency and quantity of consump-
tion, and alcohol-related problems. Participants are
asked to rate items from 0 to 4 and can receive a max-
imum possible score of 40, with higher scores indicative
of more hazardous drinking, AUDIT is highly reliable
and valid for use across a range of populations [58].
Barratt Impulsiveness Scale (BIS-11) [59]
The BIS-11 is a 30-item questionnaire assessing trait im-
pulsivity. Each item is scored on a four-point Likert scale
that ranges from “rarely/never” to “almost always”. Scores
are summed to yield an overall total score ranging from
30 to 120, with higher scores indicating greater trait im-
pulsivity. The BIS-11 also provides scores on three sub-
scales: attentional impulsiveness, motor impulsiveness,
and non-planning impulsiveness. The BIS-11 is widely
used in research and clinical contexts and has been shown
to demonstrate good reliability [59, 60].
Ratings of motivation and self-efficacy
Participants are asked to rate their motivation
(“currently, how motivated are you to reduce or quit
smoking?”) and self-efficacy (“currently, how confident
are you in your ability to quit or reduce smoking?”) on
slider scales. The scale is a 100 mm line with the left an-
chor labelled “not at all” and the right anchor labelled
“extremely”. Similar to the craving slider scale, partici-
pants indicate their response by clicking and dragging
the slider bar along the scale.
Stimulus evaluation test (ratings of likeability of smoking
and relaxing images)
Slider scales are used for the likeability ratings of the
smoking and relaxing images used in the inhibition
training task (INST). Participants are presented with the
question, “how much would you like to do this activity
right now?” and rate the images from “not at all” to “ex-
tremely”. The slider bar is presented in the middle of the
scale and participants click and drag the slider bar to in-
dicate their response.
Cognitive task
Stop Signal Task (SST) [32, 61, 62]
A smoking-specific version of the SST [30, 32, 61–63] is
utilised. The SST contains images of smoking-related
stimuli that are different images from those used in the
intervention task. Participants are presented with a
fixation cross in the centre of a screen on a white back-
ground for 500 ms. A smoking-related image (go-stimu-
lus) then appears for 1000 ms, followed by a blank white
screen for 1000 ms (inter-stimulus interval). The 16 im-
ages used in the SST are comprised of 8 pairs of images,
where one image of the pair is a cigarette pointing to the
left, and the second image is its mirror image pointing
to the right. As such, the presentation of stimuli point-
ing left or right will be equally balanced. Each of the 16
images is presented a total of 12 times.
Participants are instructed to indicate whether the
cigarette is pointing left or right by pressing the com-
puter keys “C” or “M” respectively (Fig. 2). The stop sig-
nal is a pair of red lines across the image and will appear
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on 25% of trials. It appears at a short delay (Stop Signal
Delay or SSD) after the onset of the go stimulus and
stays on screen until the inter-stimulus interval. Partici-
pants are instructed to respond as quickly as possible
but to not respond when the red lines appear. This delay
between the onset of the go signal and the stop signal
begins at 250 ms on the first stop trial, and then ad-
justed by 50 ms in a staircase manner. Successful inhib-
ition on stop trials results in the SSD increasing for the
next stop trial, while unsuccessful inhibition, where the
participant responds on a stop trial, will shorten this
delay by 50 ms. The SST consists of one practice block
of 10 trials followed by the experimental block of 192
trials. The SSD will be used to calculate the stop signal
reaction time (SSRT) as a measure of response inhibition
and the reaction time on go trials will be a measure of
behavioural impulsivity [62].
Analysis plan
All participants will be included in the intent-to-treat ana-
lyses for the primary and secondary hypotheses. If rele-
vant, per protocol analysis will include those who
complete at least four sessions of the training (as per
Lawrence et al. [36]) and achieve a training accuracy of at
least 70%. SST data will be included for those who yield
an accuracy of 40–60% on stop trials and at least 70% on
go trials. Prior to analyses, all variables will be examined
through IBM Statistical Package for Social Sciences (SPSS
Version 25) for accuracy of data entry, missing values and
fit between their distributions and the assumptions of
multivariate analysis. Any violations will be addressed as
per standard protocols [64].
Missing data will be managed using SPSS. First, a
missing value analysis will be conducted to determine
the percentage and pattern of missing data. If missing
data are found to relate to a measured participant vari-
able, those variables will be included as covariates in the
analyses. If appropriate, multiple imputation will be used
to replace missing values and the imputation model will
include baseline covariates and outcome data. Missing
data will be imputed using the Markov Chain Monte
Carlo method or the Monotone method, contingent
upon the pattern of missing data. A minimum of five
imputed datasets will be produced [65]; however, de-
pending on the percentage of missing data, a minimum
of 20 imputed datasets may be required [66]. Wherever
possible, results from the complete case analysis will be
compared with results based on imputed data. If there
are important differences, explanations will be offered.
The primary and secondary hypotheses will be analysed
using separate mixed-design ANOVAs and a Chi-square
analysis for the binary outcome. Depending on the rate of
smoking abstinence at follow up the outcome variable will
be calculated as either binary (smoking abstinence: yes/no)
or percent days abstinence if Chi-square analysis is
contraindicated due to low numbers in each cell. For all
other mixed design ANOVAs group (i.e., intervention or
control) will be included as the between-subjects factor
and time (survey time points) is the within-subjects factor.
For the smoking reduction primary hypothesis, the
repeated-measures factor will be the average number of
cigarettes smoked per day at each timepoint (i.e., baseline,
post-intervention, 1 month and 3 months post interven-
tion). For the secondary hypotheses, the repeated-measures
factor will be craving or nicotine dependence at each time-
point. The predictor hypotheses will be examined using
separate moderated regression analyses, with group as the
predictor variable, impulsivity and dose as the moderator
variable and change in smoking as the dependent variable.
The two mediation hypotheses will be analysed utilis-
ing a linear mixed model approach to examine whether
the effects of INST training on level of smoking will be
mediated by devaluation of smoking stimuli or an inde-
pendent measure of response inhibition (SSRT).
The exploratory questions related to self-confidence and
motivation will be examined using a separate mixed-design
ANOVA, with group included as the between subjects fac-
tor and self-confidence and motivation at each timepoint
included as the repeated-measures factor.
Repeated measures ANOVAs will be performed on
“go” reaction times and “no-go” accuracy to examine
stimulus-specific learning effects (100% stimuli vs. 50%
stimuli) over time (first vs. fourth training session as per
the analysis by Lawrence and colleagues to allow compar-
ability). Evidence of learning across the two time points will
be indicated by faster reaction time on 100% go stimuli and
fewer errors on 100% no-go stimuli. Any further explora-
tory analyses will be labelled as such in the publication.
Power analysis
As previous ICT studies have not targeted abstinence the
current study was powered on smoking reduction based
on Lawrence et al., [36] weight reduction ICT outcome
data. Power analysis conducted via G*power indicated that
an overall sample size of 92 is required to detect a
medium effect size (approximately .50 cohen’s d based on
Lawrence et al.) at the .05 alpha level using linear
Fig. 2 Overview of the “go” and “stop” trials in the Stop Signal Task
illustrating correct responding. Image source - permission granted:
Khamiranon D/Shutterstock [73]
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techniques (power = .80). Given that it is expected that ap-
proximately 25% will be lost to follow-up and up to 30%
would not complete a minimum of 4 sessions, the target
of the current study was set at 150 at the time of trial
registration. However, estimated target sample may be
amended if attrition is better than expected.
Discussion
Despite a decline in smoking rates prevalence of tobacco
smoking still remains unacceptably high. Many pharma-
cological and psychosocial interventions for smoking are
restricted in accessibility due to barriers such as cost
and easy access. This trial has been designed to deliver
internet-based response inhibition training in order to
offer a simple, low-cost, and easily accessible smoking
cessation/reduction intervention. As such, even small ef-
fect sizes of the intervention may translate to cumula-
tively large gains to public health. The current study
protocol has been designed to examine the efficacy of re-
sponse inhibition training to assist dependent smokers
to cease or reduce cigarette use.
The intervention has several strengths regarding its
timing, delivery and content. Firstly, the intervention
maximises the use of being an internet-based program,
which capitalises on the ability to have a wide reach
within the community at a relatively low cost. This en-
sures that the intervention is both convenient and
highly accessible given that the majority of the popula-
tion have access to a computer. Secondly, while there is
currently limited evidence to suggest that training re-
sponse inhibition to smoking cues reduces cigarette use
or craving [67], previous studies suggest that online re-
sponse inhibition training to energy-dense food images
helps individuals reduce their food intake, weight and
food liking [36, 37, 68]. Thirdly, it has been suggested
[69] that the best test of stimulus-specific response in-
hibition training is to use real-world studies that adopt
a mixed between- and within-subjects design with
repeated-measures (pre to post-intervention). This al-
lows changes from baseline to be computed for mean-
ingful/ecologically valid outcome measures.
While the usual process in translational research is to
conduct “proof of concept” studies in the lab before
attempting trials in the real-world, we decided to
proceed straight to a real-world RCT of smoking-related
response inhibition training based on the promising
findings in eating behaviour and weight change. This is
because laboratory studies can only measure acute train-
ing effects that may have little application or predictive
value for real-world effects, and because laboratory stud-
ies typically adopt a single-session, between-groups de-
sign with the dependent variable often being measured
only once post-training. This design is limited by
confounds such as only one group being exposed to
smoking cues during training. Furthermore, if the train-
ing relies on changing stimulus-response associations
[43], it may be more effective at inducing behavioural
change when conducted in real-world contexts associ-
ated with smoking (such as the home or workplace) than
when conducted in a neutral laboratory setting.
A number of limitations need to be considered. On-
going studies need to include an objective measure of
nicotine use and larger samples in order to adequately
power mediation analyses.
Considerations for future research
If this trial suggests positive effects of smoking-related
response inhibition training, future research will need to
determine how to optimise outcomes for smokers. Fur-
thermore, research could include examining which as-
pects of the intervention will produce particular effects.
This is both in terms of the training schedule (frequency,
duration, timing and location of the training) and the
mode of delivery (e.g. online vs. smartphone delivery).
Smartphone apps and digital interventions to assist with
smoking cessation are very popular but are largely lack-
ing in evidence [70]. This RCT aims to contribute to the
evidence-base for the development of new innovative
eHealth interventions for smoking cessation.
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